154 related articles for article (PubMed ID: 31289540)
41. MicroRNA-99a-5p suppresses cell proliferation, migration, and invasion by targeting isoprenylcysteine carboxylmethyltransferase in oral squamous cell carcinoma.
Sun X; Yan H
J Int Med Res; 2021 May; 49(5):300060520939031. PubMed ID: 34038200
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.
Cao M; Tian K; Sun W; Xu J; Tang Y; Wu S
Exp Ther Med; 2022 Jan; 23(1):97. PubMed ID: 34976139
[TBL] [Abstract][Full Text] [Related]
44. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
45. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.
Hei N; Chen Y; Peng S; Bao Y; Jin L
Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392
[TBL] [Abstract][Full Text] [Related]
46.
Huang C; Wang L; Song H; Wu C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
[No Abstract] [Full Text] [Related]
47. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
48. LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma.
Wang F; Ji X; Wang J; Ma X; Yang Y; Zuo J; Cui J
Onco Targets Ther; 2020; 13():243-252. PubMed ID: 32021271
[TBL] [Abstract][Full Text] [Related]
49. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
50. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
[TBL] [Abstract][Full Text] [Related]
51. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
Wang X; Zhao H; Wang P; Zhang J; Li N; Liu Y; Zhang F; Yu Y
Anticancer Drugs; 2022 Nov; 33(10):989-998. PubMed ID: 36206129
[TBL] [Abstract][Full Text] [Related]
52. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.
Gao YQ; Shi PW; Shi WK; Liu YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):658-666. PubMed ID: 34859625
[TBL] [Abstract][Full Text] [Related]
53. [Circular RNA circHIPK3 acts as the sponge of microRNA-124 to promote human oral squamous cell carcinoma cells proliferation].
Wang J; Zhao SY; Ouyang SS; Huang ZK; Luo Q; Liao L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):546-551. PubMed ID: 30078268
[No Abstract] [Full Text] [Related]
54. miR-379-5p regulates the proliferation, cell cycle, and cisplatin resistance of oral squamous cell carcinoma cells by targeting ROR1.
Meng L; Du Y; Deng B; Duan Y
Am J Transl Res; 2023; 15(3):1626-1639. PubMed ID: 37056860
[TBL] [Abstract][Full Text] [Related]
55. Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis.
Xi L; Liu Q; Zhang W; Luo L; Song J; Liu R; Wei S; Wang Y
Cancer Cell Int; 2021 Mar; 21(1):153. PubMed ID: 33663510
[TBL] [Abstract][Full Text] [Related]
56. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
57. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
58. MiR-503-5p functions as an oncogene in oral squamous cell carcinoma by targeting Smad7.
Fei Y; Shan W; Chen X
Histol Histopathol; 2020 Aug; 35(8):893-901. PubMed ID: 32319077
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
60. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]